| Literature DB >> 27974438 |
Danielle Christesen1, Ying Ting Yang1, Jason Somers1, Charles Robin1, Tamar Sztal1, Philip Batterham1, Trent Perry2.
Abstract
In Drosophila melanogaster larvae, the ring gland (RG) is a control center that orchestrates major developmental transitions. It is a composite organ, consisting of the prothoracic gland, the corpus allatum, and the corpora cardiaca, each of which synthesizes and secretes a different hormone. Until now, the RG's broader developmental roles beyond endocrine secretion have not been explored. RNA sequencing and analysis of a new transcriptome resource from D. melanogaster wandering third instar larval RGs has provided a fascinating insight into the diversity of developmental signaling in this organ. We have found strong enrichment of expression of two gene pathways not previously associated with the RG: immune response and fatty acid metabolism. We have also uncovered strong expression for many uncharacterized genes. Additionally, RNA interference against RG-enriched cytochrome p450s Cyp6u1 and Cyp6g2 produced a lethal ecdysone deficiency and a juvenile hormone deficiency, respectively, flagging a critical role for these genes in hormone synthesis. This transcriptome provides a valuable new resource for investigation of roles played by the RG in governing insect development.Entities:
Keywords: Halloween genes; cytochrome p450; ecdysteroidogenesis; immune response; molting
Mesh:
Substances:
Year: 2017 PMID: 27974438 PMCID: PMC5295594 DOI: 10.1534/g3.116.037333
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Figure 1Position and substructure of the D. melanogaster third instar larval RG. (A) GFP expression driven by 5′phm-GAL4 indicates the position of the RG in the whole larva. It is located dorso-anterior to the larval central nervous system. (B) The RG is a composite endocrine organ consisting of three distinct subtissues: the prothoracic gland, the corpus allatum, and the paired corpora cardiaca. Each subtissue synthesizes a different hormone.
Figure 2Regulation of ecdysteroidogenesis. A huge range of factors influence the ecdysteroidogenic output of the PG cells. PTTH is the major tropic regulator. When PTTH binds its receptor Torso, this activates a Ras-Raf-ERK pathway and a Ca2+-dependent pathway. Other tropic pathways include ILP signaling, TOR signaling, 20E signaling, serotonin signaling, and NO signaling, plus activin upregulates InR and Torso. JH and 20E can both downregulate ecdysteroidogenesis. Our knowledge of these regulatory signaling pathways comes from studies in lepidoptera only (italic text), or from studies in both lepidoptera and diptera (bold text). PTTH, prothoracicotropic hormone; Cam-AdCyc, calmodulin-adenylase cyclase; NO, nitric oxide; JH, juvenile hormone; 20E, 20-hydroxyecdysone; ILP, insulin-like peptide. (Adapted from Marchal ; Yamanaka ).
Figure 3Distribution of FPKM values for all genes in the Armenia14 RG (blue), the Celera RG (pink), and the Oregon-R central nervous system (green). The distribution is similar for all samples. RG samples have more genes that are very lowly expressed (FPKM < 1), while the CNS has more genes that are lowly (1 < FPKM < 10) to moderately (10 < FPKM < 50) expressed. The image was generated using CummeRbund (Trapnell ).
Most highly enriched genes in the RG, sorted by FPKM value
| Flybase Symbol | Gene Name | FPKM | Fold Enrichment | GO Term | |
|---|---|---|---|---|---|
| Biological Process | Molecular Function | ||||
| 13,305 | +113.35 | Ecdysone biosynthetic process | Ecdysteroid 25-hydroxylase activity | ||
| 12,617 | +161.98 | Ecdysone biosynthetic process | Ecdysteroid 2-hydroxylase activity | ||
| 5479 | +113.67 | Regulation of cholesterol transport | |||
| 3759 | +194.61 | Ecdysteroid biosynthetic process | |||
| 3706 | +3370.16 | ||||
| 3221 | +123.63 | ||||
| 1663 | +147.05 | ||||
| 1203 | +126.97 | Ecdysteroid biosynthetic process | Glutathione transferase activity | ||
| 992 | +145.16 | ||||
| 918 | +206.62 | Ecdysone biosynthetic process | Ecdysteroid 22-hydroxylase activity | ||
| 792 | +190.80 | ||||
| 598 | +152.41 | ||||
| 587 | +407.92 | Juvenile hormone biosynthetic process | Juvenile hormone acid methyltransferase activity | ||
| 534 | +122.62 | ||||
| 524 | +130.14 | Multicellular organism reproduction | |||
| 430 | +202.16 | ||||
| 411 | +131.97 | ||||
| 392 | +107.46 | ||||
| 191 | +161.69 | Induction of bacterial agglutination | Galactose binding | ||
| 162 | +101.70 | Metamorphosis | Protein tyrosine kinase activity | ||
| 120 | +264.62 | ||||
| 111 | +235.07 | Cell adhesion | |||
| 107 | +509.06 | Defense response to bacterium | |||
We have selected GO terms that were most informative for our study, other GO terms for each gene can be found at FlyBase (St Pierre ).
Only Cel RG data are provided, for A14 data see Table S7.
Regular text = based on experimental evidence, italics = based on predictions or assertions.
Expression of select genes involved in ecdysteroidogenesis
| Flybase Symbol | Gene Name | FPKM | Fold Enrichment | |
|---|---|---|---|---|
| Ecdysteroidogenic enzymes | ||||
| 1203 | +126.97 | <0.001 | ||
| 3759 | +194.61 | <0.001 | ||
| 0.6 | +15.73 | 0.3 | ||
| 0.0 | 0 | 1 | ||
| 775 | +59.80 | <0.001 | ||
| 13,305 | +113.35 | <0.001 | ||
| 918 | +206.62 | <0.001 | ||
| 12,617 | +161.98 | <0.001 | ||
| 0.8 | +2.68 | 0.09 | ||
| Cholesterol homeostasis | ||||
| 5479 | +113.67 | <0.001 | ||
| 139 | +1.01 | 1 | ||
| 2277 | +90.48 | <0.001 | ||
| 129 | +26.03 | <0.001 | ||
| PTTH signaling | ||||
| 162 | +101.70 | <0.001 | ||
| 97 | +1.95 | 0.006 | ||
| 11 | −2.11 | <0.001 | ||
| 0.0 | 0 | 1 | ||
| 1240 | +2.18 | <0.001 | ||
| 18 | −3.16 | <0.001 | ||
| 71 | −1.90 | <0.001 | ||
| 2528 | +1.33 | 0.05 | ||
| 14 | −1.35 | 0.02 | ||
| Insulin signaling | ||||
| 12 | −1.49 | <0.001 | ||
| 22 | +1.18 | 0.3 | ||
| 50 | +1.42 | 0.003 | ||
| Activin signaling | ||||
| 47 | −1.13 | 0.4 | ||
| 67 | +3.04 | <0.001 | ||
| 40 | −2.69 | <0.001 | ||
| Nitric oxide signaling | ||||
| 54 | −4.18 | <0.001 | ||
| 26 | +3.07 | <0.001 | ||
| 2 | −1.97 | 0.002 | ||
| TOR signaling | ||||
| 20 | −1.33 | 0.03 | ||
| 17 | +1.48 | 0.02 | ||
| 23 | +1.04 | 0.8 | ||
| Serotonin signaling | ||||
| 1 | −5.70 | <0.001 | ||
| JH signaling | ||||
| 4 | −2.90 | <0.001 | ||
| 4 | −2.23 | <0.001 | ||
| 20E signaling | ||||
| 80 | +1.59 | <0.001 | ||
| 28 | −1.93 | 0.01 | ||
Only Cel RG data are provided, for A14 data see Table S8.
Genes located in heterochromatic regions were not included in reference genome. Reads corresponding to these genes were therefore not aligned by Tophat, hence the 0.0 FPKM score.
Ring gland-enriched cytochrome p450 genes, sorted by FPKM value
| Cytochrome p450 | FPKM | Fold Enrichment | Annotated Biological Process | Ubiquitous RNAi Knockdown | Clade Stability Across | |
|---|---|---|---|---|---|---|
| 13,305 | +113.35 | <0.001 | Ecdysone biosynthetic process | Lethal | Stable | |
| 12,617 | +161.98 | <0.001 | Ecdysone biosynthesis process | n/a | Stable | |
| 992 | +145.01 | <0.001 | Lethal | Stable | ||
| 918 | +206.62 | <0.001 | Ecdysone biosynthetic process | n/a | Stable | |
| 107 | +509.06 | 0.007 | Defense response to bacterium | Viable | Gene loss | |
| 96 | +8.42 | <0.001 | n/a | Stable | ||
| 70 | +11.96 | <0.001 | Viable | Gene gain | ||
| 52 | +77.94 | 0.002 | Negative regulation of Wnt signaling pathway | n/a | Gene loss | |
| 37 | +3.57 | <0.001 | n/a | Stable | ||
| 20 | +1.84 | <0.001 | Wing disc development | Viable | Gene gain | |
| 19 | +2.72 | 0.08 | Lipid metabolic process | Lethal | Stable | |
| 15 | +17.58 | <0.001 | Sensory organ development | n/a | Stable | |
| 15 | +3.68 | <0.001 | Lethal | Gene loss | ||
| 13 | +2.36 | <0.001 | Wing disc development | Viable | Gene gain | |
| 6 | +28.61 | <0.001 | Ecdysteroid catabolic process | Lethal | Stable |
We selected GO terms that were most informative for our study; other GO terms for each gene can be found at FlyBase (St Pierre ).
Only Cel RG data are provided, for A14 data see Table S9.
Regular text = based on experimental evidence, italics = based on predictions or assertions.
Chung , Guittard , and Qiu .
Good .
Figure 4RNAi knockdown of RG-enriched cytochrome p450s. (A) Cytochrome p450s were knocked down ubiquitously (tubulin-GAL4), and with a PG-specific driver (5′phm-GAL4), and the resulting progeny scored for viability (n > 250). Each bar represents mean ± SEM. Significance was calculated using a Student’s t-test (*** P < 0.0001). (B, C) Representative pupae and larvae at the time of lethality and equivalent wild-type individuals. Ubiquitous knockdown is shown for Cyp4g1 and Cyp4d2. PG-specific knockdown is shown for Cyp6u1. (D) Adults that survived ubiquitous Cyp4d2 knockdown had variable, asymmetrical melanization on their wings (arrows). (E) qPCR reveals significantly lowered levels of Kr-h1, a juvenile hormone primary response gene, and Cyp6g2 transcripts in Cyp6g2 knockdown larvae. Significance was calculated using a Student’s t-test (* P < 0.05, *** P < 0.0001). (F) Quantity of ecdysteroids in the hemolymph and RG-CNS complexes of wandering third instar larvae is severely reduced in Cyp6u1 PG-RNAi larvae. Bars represent the mean ± SEM of three independent samples. Significance was calculated using a Student’s t-test (* P < 0.05).
Figure 5RNAi knockdown of Cyp6u1 results in lethality throughout larval and pupal development. The percentage at each developmental stage per day posthatching (n > 40) is shown. Each color represents a different developmental stage, with lighter shades representing dead individuals. (A) For ubiquitous knockdown, lethality was observed at the first larval instar (32%), second larval instar (10%), and third larval instar (32%). (B) For PG-specific knockdown, lethality was observed at the first larval instar (18%), second larval instar (16%), third larval instar (26%), pupation (4%), and eclosion (34%).
Top ranked biological processes represented by RG-enriched transcripts
| Annotation Cluster | Flybase Symbol | Gene Name |
|---|---|---|
| Enrichment score: 2.76 | ||
| GO:0008610 - lipid biosynthetic process | ||
| GO:0006694 - steroid biosynthetic process | ||
| GO:0008202 - steroid metabolic process | ||
| GO:0034754 - cellular hormone metabolic process | ||
| GO:0042446 - hormone biosynthetic process | ||
| GO:0042445 - hormone metabolic process | ||
| GO:0010817 - regulation of hormone levels | ||
| GO:0042181 - ketone biosynthetic process | ||
| GO:0045456 - ecdysteroid biosynthetic process | ||
| GO:0045455 - ecdysteroid metabolic process | ||
| GO:0016125 - sterol metabolic process | ||
| GO:0006697 - ecdysone biosynthetic process | ||
| GO:0016126 - sterol biosynthetic process | ||
| GO:0008205 - ecdysone metabolic process | ||
| GO:0019748 - secondary metabolic process | ||
| Enrichment score: 1.68 | ||
| GO:0006631 - fatty acid metabolic process | ||
| GO:0006633 - fatty acid biosynthetic process | ||
| GO:0016053 - organic acid biosynthetic process | ||
| GO:0046394 - carboxylic acid biosynthetic process | ||
| Enrichment score: 1.55 | ||
| GO:0019730 - antimicrobial humoral response | ||
| GO:0019731 - antibacterial humoral response | ||
| GO:0009617 - response to bacterium | ||
| GO:0006959 - humoral immune response | ||
| GO:0006955 - immune response | ||
| GO:0042742 - defense response to bacterium | ||
| GO:0006952 - defense response | ||
Gene ontology enrichment analysis was carried out using the Functional Annotation Clustering tool of (DAVID 6.7) (Huang ). Clusters with enrichment scores >1.3 (equivalent to nonlog P < 0.05) are shown.
RG-enriched serine proteases, sorted by FPKM value
| Flybase Symbol | Gene Name | FPKM |
|---|---|---|
| 535 | ||
| 108 | ||
| 64 | ||
| 63 | ||
| 46 | ||
| 39 | ||
| 34 | ||
| 22 | ||
| 21 | ||
| 20 | ||
| 18 | ||
| 18 | ||
| 16 | ||
| 15 | ||
| 12 | ||
| 11 | ||
| 11 | ||
| 11 | ||
| 9 | ||
| 7 | ||
| 5 | ||
| 4 |
Only Cel RG data are provided, for A14 data see Table S12.
RG expression of key genes in the immune response pathways
| Flybase Symbol | Gene Name | FPKM | Fold Enrichment | |
|---|---|---|---|---|
| Toll Pathway | ||||
| 26 (62 | −1.46 (+1.64 | <0.001 | ||
| 15 | +1.74 | <0.001 | ||
| 16 | +1.66 | 0.2 | ||
| 27 | −1.19 | 0.2 | ||
| 97 | +1.80 | <0.001 | ||
| 26 | +2.71 | <0.001 | ||
| 31 | +10.77 | 0.001 | ||
| Imd Pathway | ||||
| 9 | +5.43 | <0.001 | ||
| 23 | +1.86 | 0.5 | ||
| 15 | +3.06 | 0.1 | ||
| 40 | +3.74 | <0.001 | ||
| 27 | −1.38 | 0.01 | ||
| 34 | −1.19 | 0.3 | ||
| 16 | +4.85 | <0.001 | ||
| 30 | +2.07 | <0.001 | ||
| 3.5 | +9.32 | 0.2 | ||
Unless otherwise stated, only Cel RG data are provided. For A14 data see Table S13.
Cel and A14 results were significantly different, therefore A14 data are provided in parentheses.